文献速递腹部技术与安全MRUS

PREMIUM研究放射学考量:简化MRI与超声肝癌筛查

Radiology considerations for the PREMIUM study: a multicenter randomized controlled trial of abbreviated MRI versus ultrasound for liver cancer screening in cirrhosis.
PubMed 文献 · Abdom Radiol (NY) · 2026-09-06

PREMIUM是一项多中心随机对照试验,比较动态增强简化MRI联合AFP与超声联合AFP在肝硬化患者肝癌筛查中的作用。计划在超过47个退伍军人医疗中心随机4700例参与者,主要终点为HCC相关死亡率。目前35个中心已启动,1085例患者已随机,并建立标准化影像方案、结构化报告和图像库。

要点

  • 简化MRI采用多期增强序列以支持LI-RADS评分,肾功能不全或对比剂过敏者有平扫方案。
  • 超声方案遵循US LI-RADS标准,报告需记录可视化评分和随访建议。
  • 图像库预计纳入超过2万例肝脏MRI和超声,供影像组学与AI研究使用。

核心结论

  • PREMIUM研究旨在明确动态增强简化MRI联合AFP筛查HCC能否较超声联合AFP降低HCC相关死亡率。
  • 通过统一影像方案与结构化报告减少多中心实施的异质性,保证每中心按方案筛查。

研究设计与样本

  • 研究类型为多中心随机对照试验,由退伍军人事务部资助,计划在超过47个中心随机4700例肝硬化患者。
  • 筛查间隔为每半年一次,持续最长八年,主要终点为HCC相关死亡率。
  • 已启动35个中心并随机1085例患者,建立影像方案、培训计划和持续质量控制。

关键影像表现/征象

  • 动态增强简化MRI方案采用多时相增强后成像,可进行LI-RADS评分。
  • 平扫简化MRI方案仅用于研究期间出现肾功能损害或对比剂过敏的受试者。
  • 超声方案符合US LI-RADS标准,结构化报告涵盖影像所见、可视化评分与随访建议。

诊断标准与关键数值

  • 动态增强简化MRI方案采用多期增强后成像以支持LI-RADS评分。
  • 超声筛查方案遵循US LI-RADS标准进行影像采集与报告。
  • 无对照或外部参考标准,研究评估标准主要依据LI-RADS结构化报告。

临床应用与阅片要点

  • 阅片时应按LI-RADS结构化模板书写所见、可视化评分和随访建议,减少多中心报告差异。
  • 动态增强序列缺失时不能按增强方案评分,是否启用平扫方案需结合临床及肾功能变化判断。
  • 超声报告中应同时评估成像质量与可视化程度,避免因扫查差异误判肝脏局灶病变。

局限性

  • 原文属于研究设计与方案介绍,尚未报告两组筛查检出率、死亡率或影像诊断准确性结果。
  • 入组以退伍军人医疗中心患者为主,结果推广至其他肝硬化人群时可能受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

This paper describes the rationale and radiology considerations in the implementation of the Preventing Liver Cancer Mortality through Imaging with Ultrasound versus MRI (PREMIUM) study. PREMIUM is a multicenter, randomized controlled trial sponsored by the Department of Veterans Affairs comparing dynamic contrast-enhanced (DCE) abbreviated MRI (aMRI) plus serum AFP versus ultrasound (US) plus serum AFP for hepatocellular carcinoma (HCC) screening in patients with cirrhosis. PREMIUM aims to randomize 4,700 participants across over 47 Veterans Affairs Medical Centers to semiannual surveillance for up to eight years, with HCC-related mortality as the primary endpoint. To date, 35 sites have been activated with 1,085 patients randomized. To ensure uniform implementation and reporting of per-protocol screening, the PREMIUM Radiology Workgroup developed standardized imaging protocols, structured LI-RADS-based reporting templates, and a centralized training program for radiologists and technologists. They also perform ongoing quality control on both scans and reports. The aMRI protocols utilize multiphasic post-contrast imaging to allow LI-RADS scoring. A non-contrast-enhanced aMRI protocol is available for participants who develop renal impairment or contrast allergy during the study. US protocols conform to US LI-RADS standards. Structured reporting promotes consistency in documentation of findings, visualization scores, and follow-up recommendations. A centralized Image Repository was established, incorporating advanced de-identification methods to remove metadata and pixel-embedded protected health information from imaging files. More than 20,000 curated liver MRI and US exams are anticipated, supporting both trial outcomes and future radiomics and artificial intelligence research. PREMIUM aims to determine whether screening for HCC with a DCE aMRI protocol reduces HCC-related mortality and also facilitates ancillary studies utilizing the Image Repository.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Dunn, Dani, Sharma, et al. Radiology considerations for the PREMIUM study: a multicenter randomized controlled trial of abbreviated MRI versus ultrasound for liver cancer screening in cirrhosis. Abdom Radiol (NY). 2026. PMID: 42701973. doi:10.1007/s00261-026-05720-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。